Literature DB >> 23512890

High-density lipoprotein cholesterol affects early endothelial progenitor cell number and endothelial function in obese women.

F Rossi1, C Bertone, E Michelon, M J Bianco, V Santiemma.   

Abstract

OBJECTIVE: In order to improve our understanding of high-density lipoprotein cholesterol (HDL-C) cardiovascular (CV) impact in obesity, the association of HDL-C plasma level with circulating early endothelial progenitor cell (early-EPC) number and endothelium-dependent vasodilatation (EDV) in obese women with normal or high low-density lipoprotein cholesterol (LDL-C) plasma levels was evaluated. DESIGN AND METHODS: One hundred thirteen obese female subjects and a control group of 78 healthy female subjects were recruited. Circulating early-EPC were assessed by single- and two-color flow cytometric analyses with a fluorescence activated cell sorting (FACScan) flow cytometer. EDV was evaluated as response to ischemia by strain gauge plethysmography.
RESULTS: Both early-EPC number and EDV were significantly decreased in obese women compared with the control group. Obese women with low HDL-C showed a further decrease of early-EPC and EDV in the presence of both high or normal LDL-C plasmatic levels. In the normal HDL-C level subgroup, hypercholesterolemic and nonhypercholesterolemic subjects showed no difference in early-EPC number, whereas slight EDV impairment was present in hypercholesterolemic subjects.
CONCLUSION: In obese women, low HDL-C is associated to decreased early-EPC number and impaired EDV, suggesting the need to assess whether evaluation of early-EPC and EDV may increase HDL-C prognostic value in the stratification of CV risk.
Copyright © 2013 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512890     DOI: 10.1002/oby.20367

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  6 in total

Review 1.  Functional neural-bone marrow pathways: implications in hypertension and cardiovascular disease.

Authors:  Jasenka Zubcevic; Monica M Santisteban; Teresa Pitts; David M Baekey; Pablo D Perez; Donald C Bolser; Marcelo Febo; Mohan K Raizada
Journal:  Hypertension       Date:  2014-03-31       Impact factor: 10.190

2.  Involvement of NADPH oxidases and non-muscle myosin light chain in senescence of endothelial progenitor cells in hyperlipidemia.

Authors:  Ting-Bo Li; Jie-Jie Zhang; Bin Liu; Wei-Qi Liu; Yan Wu; Xiao-Ming Xiong; Xiu-Ju Luo; Qi-Lin Ma; Jun Peng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-12-19       Impact factor: 3.000

3.  Reverse-D-4F Increases the Number of Endothelial Progenitor Cells and Improves Endothelial Progenitor Cell Dysfunctions in High Fat Diet Mice.

Authors:  Yang Nana; Jiao Peng; Zhang Jianlin; Zhang Xiangjian; Yao Shutong; Zhan Enxin; Li Bin; Zong Chuanlong; Tian Hua; Si Yanhong; Du Yunsai; Qin Shucun; Wang Hui
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

4.  Downregulated GTCPH I/BH4 Pathway and Decreased Function of Circulating Endothelial Progenitor Cells and Their Relationship with Endothelial Dysfunction in Overweight Postmenopausal Women.

Authors:  Ying Luo; Zhenhua Huang; Jinli Liao; Zhihao Liu; Xiaopeng Li; Shun Yao; Hao He; Dajun Hu; Zi Ren; Haitao Zeng; Quanneng Yan; Hong Zhan
Journal:  Stem Cells Int       Date:  2018-07-01       Impact factor: 5.443

5.  Correlation between NADPH oxidase-mediated oxidative stress and dysfunction of endothelial progenitor cell in hyperlipidemic patients.

Authors:  Ting-Bo Li; Yin-Zhuang Zhang; Wei-Qi Liu; Jie-Jie Zhang; Jun Peng; Xiu-Ju Luo; Qi-Lin Ma
Journal:  Korean J Intern Med       Date:  2017-09-13       Impact factor: 2.884

6.  Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus.

Authors:  Daniela Lucchesi; Simona Georgiana Popa; Veronica Sancho; Laura Giusti; Monia Garofolo; Giuseppe Daniele; Laura Pucci; Roberto Miccoli; Giuseppe Penno; Stefano Del Prato
Journal:  Cardiovasc Diabetol       Date:  2018-06-05       Impact factor: 9.951

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.